… line is an induced pluripotent stem (iPS) cell line derived from PD patient skin cells that will produce a green … of Parkinson’s Disease: Cell lines generated resulting from this project will allow us to proceed to the next stage … PD patients. To start this project, we received funding from the Rapid Response Innovation Program to make cell …

… model of PD, we have tested whether it protects rats from over-expression of alpha-synuclein. We have now shown … that this novel therapeutic can, indeed, protect animals from symptoms of PD due to the over-expression of alpha-synuclein and that this also occurs by protection from mitochondrial stress.  …

… This grant builds upon the research from a prior grant: Utilization of Aptamers to Prevent … aptamer, which can bind to alpha-synuclein and prevent it from clumping. Aptamers are short strands of the cell's … aptamer, which can bind to alpha-synuclein and prevent it from clumping. Aptamers are short strands of the cell's …

… 2019, who are nearing graduation, recently shared learnings from studies they've led during their training  on an … of patients with a LRRK2 mutation who had DBS with records from those who did not undergo surgery. She also looked at records from people with Parkinson's but without a LRRK2 mutation …

… the latest research. In this year's course, 88 attendees from across North and South America learned from 12 world-renowned experts and six patients as well as … for Neurology Residents was made possible with support from the Edmond J. Safra Foundation and The Michael J. Fox …

… to determine which is the best one for you. DBS Devices from Abbott  Abbott has two DBS devices : Infinity and … with Apple iOS software and controllers.   DBS Devices from Boston Scientific  Boston Scientific’s Vercise became … and lasts three to five years.   DBS Devices from Medtronic  Medtronic’s DBS was the first to be FDA …